Every round, fund close and exit we can source, with the article it was reported in and what it actually said.
Roundup of three trans-Tasman raises: crime-intelligence software maker Auror's $72.6m Series C, underground mining-robot firm ADR's $2m round, and mentorship platform Matched's angel backing below $500,000.
Smart50 profile ranking telehealth provider Midnight Health third, noting its founders, Queensland base and earlier $40 million backing from NIB across several rounds.
Interactive systems chief Simon Durkin explains how serving clients through their acquisitions fuels growth; ex-Datacom Australia head Alex Coates joins as chief executive from January 2025.
SmartCompany's Smart50 Awards 2024 profile ranks agtech Goterra ninth. The Canberra business turns food waste into animal feed using robot-managed maggots, with customers including Woolworths and the City of Sydney.
Industry minister Ed Husic told a Tech Council summit the National Reconstruction Fund is close to its first investments after asking for a $300m drawdown; the piece recaps federal tech funding moves including PsiQuantum's.
US authorities sentenced Roman Sterlingov, who ran the darknet bitcoin mixer Bitcoin Fog, to over twelve years for money laundering, with forfeiture of roughly $395 million in illicit proceeds after a landmark prosecution.
Interview with Sunroom co-founder Michelle Battersby on her path from Bumble's first Australian employee and Kic CMO to founding the creator platform, plus investor Nick Crocker on backing the team.
Industry body executive Louise McGrath has won election to the standards body's board, with formal confirmation set for late November at the group's yearly meeting.
Roundup: Artrya's $5m placement, Traffic Technologies' $2.8m entitlement offer, Rhythm's R&D tax refund, Hydramech's grant, Orthocell hires, a Standards Australia board election, and Aristocrat's agreed Plarium sale.
Sweden's Thule is buying Melbourne phone-mount maker Quad Lock in a $500 million deal; Quadrant Private Equity and the founders are selling their stakes. The piece recalls Quad Lock's crowdfunding start and Smart50 appearances.
Also addtocart.com.au
ERP specialist Wild Tech has hired Matthew Rodgers, previously at sa.global, to lead its Microsoft business across Asia Pacific from Kuala Lumpur and strengthen links between Southeast Asia and A/NZ.
Palisade has recruited three senior renewables development executives away from Squadron Energy for Intera Renewables, its clean energy platform, to build a new division targeting co-development projects in Australian renewables.
The renewable energy agency has committed $28.6 million in grants so Linfox and Toll can electrify their freight fleets with dozens of electric trucks, alongside fresh program priorities opening for applications.
Also @AuManufacturing
Bitcoin Fog founder Roman Sterlingov received a 12.5-year prison term and a roughly $395.5 million forfeiture judgment, part of US authorities' wider pursuit of cryptocurrency mixer founders.
An executive interview with KP Rx founder Hashan De Silva on building a specialist healthcare venture firm investing in biotech and medical devices across Australia and New Zealand.
Crimson Education has completed a NZ$67 million Series D with Movac leading and a valuation above NZ$1 billion; fulfilment-robotics maker Nexobot has raised $400,000 pre-seed from Skalata and Antler.
Orkestra, a Melbourne clean-energy software firm, won $2.77 million in ARENA co-funding to accelerate commercial EV charger rollout; a year earlier it banked $2 million in seed funding from Tidal Ventures.
Roundup of manufacturing briefs: Macquarie University opens a silicon research lab with Atto Devices, Spectur's managing director resigns, Provaris and Noxopharm secure new funding, and Livium sells its lithium project stake.
Koppers Wood Products has opened its upgraded pine processing facility at Longford, Tasmania, supported by a $250,000 Tasmanian government grant to cut waste and lift treated-timber output.
Vanadium company Australian Vanadium says the first study phase for its subsidiary's battery storage project is complete, and flags future funding options; earlier federal program money backs its Gabanintha resource.
Perth wave-energy startup WaveX received a $2.5 million federal grant and is hunting more funding for an Albany prototype; its founder says oil and gas supply chains make the device cost-competitive.
Profile of founder Nicole Gibson, whose emotion-tracking wearable startup InTruth has raised $9.5 million to date, including a $9.1 million non-dilutive grant from a UK family office, ahead of a planned launch.
A federal opposition senator attacks Labor's solar manufacturing program and SunDrive, which has cut staff and changed CEO while pursuing partnerships with AGL and Trina Solar to localise panel production.
The Victorian government's VC fund Breakthrough Victoria slipped to a loss, its annual report showing startup investments, cost cutting and boardroom departures amid criticism of its spending and performance.
JustFund, a Sydney lender covering legal costs in separations, has disclosed a $5.7 million seed round led by Xilium Capital, plus venture debt and mezzanine funding from family offices.
Podcast interview with Diffuse Energy CTO James Bradley on winding up the wind turbine startup after chip shortages, its ARENA-backed telco tower trial, CSIRO ON origins and his accelerator work with University of Newcastle.
1414 Degrees says its SiBox silicon heat-storage technology is nearing commercialisation, with federal expansion support on offer, and recalls a February consortium grant win for its SiPHyR hydrogen project.
University of Melbourne researchers describe a faster acoustic bioprinting method for human-like tissue; PhD candidate Callum Vidler's project recently won a $199,482 seed grant via the national AEA pilot program.
Optiscan Imaging has agreed to work with Monash University on AI for its next-generation gastrointestinal endomicroscope, a project that has already drawn close to $1 million under the CRC-P grant programme.
Profile of Australian biotech Recce Pharmaceuticals, whose synthetic antibiotic candidates target drug-resistant infections, covering its leadership team, FDA designation, clinical trial progress and a government underwriting of its R&D rebate.
PolyActiva reported Phase 2 results showing its PA5108 ocular implant lowered eye pressure safely in glaucoma patients, with a phase 2b trial planned, after presentations at two ophthalmology conferences.
Round-up reporting Neara's $45 million Series C, Alimetry's US$18 million Series A2, Earthodic's US$4 million seed, and Antler's latest residency intake of startups each receiving $225,000 for 12% stakes.
Also Startup Daily
A fresh sale of existing shares has lifted Canva's valuation to about $48.7 billion from $38.5 billion in January, boosting the co-founders' wealth and edging the design software firm toward a possible public listing.
Jelix's note explains why its fund led satellite thruster startup VXB Aerospace's $1.2 million seed round, citing the team's expertise, customer letters of intent, market growth, and acceptance into Techstars Space.
Paloma announces a second fund it is opening, seeking A$25 million to back studio-built GenAI ventures and breakout portfolio companies across Australia and New Zealand; no close is reported.
Roundup of Australian manufacturing news: OncoSil, K-TIG and Aurora Labs complete or commit raises, Amplia opens an offer, Siemens agrees to buy Altair, CSIRO unveils a printed-solar facility, and a WA medical alliance grows.
Startupbootcamp has picked 15 startups for the second intake of its Sustainable Fintech Accelerator, spanning themes from fraud prevention to embedded finance, with Tim Poskitt returning to lead the program.
AgFunderNews weekly roundup: new raises for Udaan, Matteco, Foodsi, Bendi, Revo Foods, Paleo, Tebrio and Earthodic; Blue Evolution and Blu3 merge; USDA and Finnish grants; three executive appointments announced.
Breakthrough Victoria reflects on its third annual report: over $350 million committed across 44 investments, including five follow-on investments worth over $35 million in the past financial year across five named portfolio companies.
Neara, an Australian AI infrastructure startup, raised $45 million led by EQT, Partners Group and Square Peg Capital, with Skip Capital and Prosus Ventures returning; funds target North American and European expansion.
Hadean Energy, a hydrogen electrolysis venture formed by RFC Ambrian with CSIRO, has won an Australia-UK government grant to develop a 5kW demonstration unit, working with EDF Energy and Certscape.
Five Western Australian mining-technology firms have received government grants totalling $1.25 million via MRIWA's METS Innovation Program, including a battery-cooling developer and an efficient conveyor builder.
Also Startup News (WA)
SmartCompany profiles Gentoo.earth, a carbon-removal intelligence platform founded by Juliet Kirby, now scaling from San Francisco; the piece recalls an angel round and undisclosed pre-seed backing including Admiralty Capital Group.
Green Gravity has begun early studies for a gravitational energy storage project in Mount Isa mine shafts, working with Glencore and the local council, weeks after landing $9 million to advance its technology.
Profile of two ex-Macquarie executives whose new impact investing arm inside Palisade has assembled a $450m fund aimed at emissions, waste and inequality goals.
The renewable energy agency is putting nearly $4m toward AnteoTech's silicon anode work, part of an $11.1m three-year Brisbane project to commercialise longer-lasting lithium-ion battery technology.
Vaxxas, a Brisbane biotech, has taken a worldwide licence from the US NIH to an RSV antigen candidate, aiming to advance it toward a Phase I study; another trial runs with BARDA funding.
Brisbane maker of recyclable water-resistant paper coatings has closed an oversubscribed seed round led by FTW Ventures to lift production and enter the US market, with its 2023 pre-seed backers returning.
Also AgFunderNews·SmartCompany
A OneVentures blog stub links to Capital Brief's report that the venture firm is approaching a major growth milestone, has added key staff, and is preparing a fresh fund.
Aravax has finished enrolling 95 young patients in its Phase 2 peanut-allergy immunotherapy trial across US and Australian sites, with results expected in the first half of 2026.